TMEM33作为宫癌的预后生物标志物及其与免疫透的相关性
Hui Zhang1, Jun Wang1, Ji Yang1
1Department of Ultrasound, Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, China.
Mediators of inflammation
|June 5, 2023
概括
转膜蛋白33 (TMEM33) 在宫癌 (CC) 中过度表达,与预后不佳和免疫细胞透的改变相关. TMEM33可以作为CC的预后生物标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 宫癌 (CC) 是一个重要的全球健康问题.
- 跨膜蛋白33 (TMEM33) 与各种癌症的不良预后有关.
- 在CC中TMEM33的作用及其瘤微环境仍然不完全理解.
研究的目的:
- 为了全面调查TMEM33在宫癌的预后价值.
- 探索TMEM33表达与CC中的瘤微环境之间的关联.
- 评估TMEM33作为CC预后和免疫透的潜在生物标志物.
主要方法:
- 在CC和非瘤组织中对TMEM33表达的比较分析.
- 全癌症TMEM33表达分析.
- 对TMEM33水平与患者生存结果 (总生存率和无疾病生存率) 之间的相关性分析.
- 多变量分析以评估独立的预后意义.
- 免疫细胞透分析.
- 在体外实验中评估TMEM33对CC细胞增殖和入侵的淘汰效应.
主要成果:
- 与非瘤组织相比,CC标本中的TMEM33表达显著更高.
- 高TMEM33表达与CC患者的整体存活率和无病存活率较差有关.
- TMEM33表达独立预测了CC的预后.
- TMEM33水平与透的免疫细胞负相关,包括树突细胞,巨细胞,血细胞和各种T细胞子集.
- TMEM33敲击抑制了CC细胞的增殖和入侵.
结论:
- TMEM33在宫癌中过度表达,并作为一个独立的预后生物标志物.
- TMEM33表达与CC瘤微环境中的免疫细胞透变化有关.
- TMEM33代表了一种潜在的治疗标和生物标志物,用于评估宫癌的预后和免疫状态.
相关概念视频
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
01:27Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575